Search - tctmd.com

Displaying 881 - 900 of 5439

Sort: Relevancy | Date

Presentation TCT 2023

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

Presenter: Isaac George

October 25, 2023

Presentation TCT 2023

Pro: For Symptoms Only - There is no Evidence for Other Benefit

Presenter: Anita Asgar

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS

Presenter: Stephan Windecker

October 24, 2023

Presentation TCT 2023

Outcomes of TAVR and SAVR in Bicuspid AS: Data From the STS/TVT Registry

Presenter: Tsuyoshi Kaneko

October 24, 2023

Presentation TCT 2023

TAVR Techniques in Bicuspid Anatomy: Valve Selection, Sizing, and Positioning

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

CT Guidance for TAVR Planning in Bicuspid AS in 2023

Presenter: Hasan Jilaihawi

October 24, 2023

Presentation TCT 2023

We Need an RCT, and Here Is How I Would Like to Design It

Presenter: David Cohen

October 24, 2023

Presentation TCT 2023

Case Resolution: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy

Presenter: Vivian Ng

October 24, 2023

Presentation TCT 2023

Are Outcome Trials Necessary for Renal Denervation Therapies?

Presenter: Ajay Kirtane

October 24, 2023

Presentation TCT 2023

Index SAVR in Young Patients With Bicuspid AS Is Better for Lifetime Management

Presenter: Basel Ramlawi

October 24, 2023

Presentation TCT 2023

What Will the Next Trial Designs Look Like for Renal Denervation?

Presenter: Eric Secemsky

October 24, 2023

Presentation TCT 2023

Index TAVR in Young Patients With Bicuspid AS is Better for Lifetime Management

Presenter: Amit Vora

October 24, 2023

Presentation TCT 2023

Coronary Keynote Lecture: Evidence-Based Practical Guide to the Use of Drug Coated Balloons in the Coronary Arteries

Presenter: Bruno Scheller

October 24, 2023

Presentation TCT 2023

Case Presentation: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy

Presenter: Vivian Ng

October 24, 2023

Presentation TCT 2023

Clinician Perspectives

Presenter: Naomi Fisher

October 24, 2023

Presentation TCT 2023

Industry Perspectives

Presenter: Sandeep Brar

October 24, 2023

Presentation TCT 2023

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Presenter: Nadira Hamid

October 24, 2023

Presentation TCT 2023

Trialist Perspectives

Presenter: Felix Mahfoud

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Advertisement

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

Pro: For Symptoms Only - There is no Evidence for Other Benefit

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS

Outcomes of TAVR and SAVR in Bicuspid AS: Data From the STS/TVT Registry

TAVR Techniques in Bicuspid Anatomy: Valve Selection, Sizing, and Positioning

CT Guidance for TAVR Planning in Bicuspid AS in 2023

We Need an RCT, and Here Is How I Would Like to Design It

Case Resolution: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy

Are Outcome Trials Necessary for Renal Denervation Therapies?

Index SAVR in Young Patients With Bicuspid AS Is Better for Lifetime Management

What Will the Next Trial Designs Look Like for Renal Denervation?

Index TAVR in Young Patients With Bicuspid AS is Better for Lifetime Management

Coronary Keynote Lecture: Evidence-Based Practical Guide to the Use of Drug Coated Balloons in the Coronary Arteries

Case Presentation: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy

Clinician Perspectives

Industry Perspectives

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Trialist Perspectives

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content